Liarozole

CAS No. 115575-11-6

Liarozole ( R75251 dihydrochloride )

Catalog No. M23335 CAS No. 115575-11-6

Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 178 In Stock
10MG 295 In Stock
25MG 502 In Stock
50MG 709 In Stock
100MG 1008 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Liarozole
  • Note
    Research use only, not for human use.
  • Brief Description
    Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
  • Description
    Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).Liarozole dihydrochloride is an imidazole derivative;?it is being investigated as a non-hormonal agent in prostate cancer and in the treatment of various other cancers and skin disorders.?
  • Synonyms
    R75251 dihydrochloride
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    115575-11-6
  • Formula Weight
    308.8
  • Molecular Formula
    C17H13ClN4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    ClC1=CC(C(C2=CC=C3NC=NC3=C2)N4C=CN=C4)=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bryson HM, et al. Liarozole. Drugs Aging. 1996 Dec;9(6):478-84; discussion 485.
molnova catalog
related products
  • Verapamil

    Verapamil is a calcium channel blocker and an orally active and effective inhibitor of P-gp.

  • Ambroxol

    Ambroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

  • 1-Ethynylpyrene

    1-Ethynylpyrene is an aryl acetylenic inhibitor of CYTP450 1A1(IC50=0.18 μM), 1A2(IC50 = 0.32 μM), and 2B1(IC50 = 0.04 μM).